Renishaw 3D Printed Medical Device Breaks Ground in Parkinson’s Drug Trial
Renishaw additive manufacturing has played a pivotal role in the recent clinical trial of an experimental treatment for Parkinson’s Disease. Documented in a two part-series produced by the BBC titled The Parkinson’s Drug Trial: A Miracle Cure? this trial includes the novel development of 3D printed medical device capable of delivering drugs directly to affected parts of the brain. After 40-80 weeks in-situ, the implants have become part of a potentially landmark advance in the treatment of this long-term degenerative disorder.
